Understanding how HIV proteins are processed for virus maturation

Dynamics and Evolution of HIV Gag and GagPol processing

['FUNDING_OTHER'] · UNIV OF MASSACHUSETTS MED SCH WORCESTER · NIH-11118329

This study is looking at how the HIV-1 virus grows and gets ready to infect cells by understanding how certain proteins work together, and the findings could help develop new treatments for people living with HIV.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIV OF MASSACHUSETTS MED SCH WORCESTER (nih funded)
Locations1 site (WORCESTER, UNITED STATES)
Trial IDNIH-11118329 on ClinicalTrials.gov

What this research studies

This research investigates the maturation process of the HIV-1 virus, focusing on how the viral protease activates and processes specific proteins called Gag and GagPol. By using advanced molecular dynamics simulations, the study aims to uncover the timing and order of these proteolytic events, which are crucial for the virus's ability to mature and infect cells. The research will also explore the structural features of these proteins and how they interact with each other during this process. Patients may benefit from insights gained that could lead to new therapeutic strategies targeting HIV maturation.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV who are seeking new treatment options.

Not a fit: Patients who are not infected with HIV or those who have already achieved viral suppression may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that inhibit HIV maturation, potentially improving outcomes for patients living with HIV.

How similar studies have performed: Previous research has shown promise in targeting viral maturation processes, suggesting that this approach could yield significant advancements in HIV treatment.

Where this research is happening

WORCESTER, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.